UPenn PRC receives $6.5 million grant for community health solutions

The University of Pennsylvania Prevention Research Center (UPenn PRC) has been awarded a grant totaling $6.5 million over five years from the Centers for Disease Control and Prevention (CDC) to work with communities in the Philadelphia area to develop, test, and evaluate solutions to public health problems, with a particular focus on cancer.

Gaming Amylyx stock reactions to the next ALS drug test, and a chat with CRISPR’s CEO about a new investor

This week, a preview of the TUDCA study in ALS and thoughts on how it might impact Amylyx Pharmaceuticals. Also, I chatted with CRISPR Therapeutics

February 15, 2024

Coeptis licenses Deverra Therapeutics’ clinical stage assets

DVX201 is being assessed in a Phase I clinical study for treating haematologic malignancies and viral infections. Credit: Kateryna Kon/Shutterstock.com. Coeptis Therapeutics has exclusively licensed

August 18, 2023

Rastafari Psychedelic Retreat & What Makes a Rastafari Shaman

We’re well into booking season for those winter getaways. Fancy something a bit more adventurous and profound? How about a Rastafari psychedelic retreat in beautiful

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.